Automatic Deep Learning OCT Analysis Algorithm Reliably Reproduces Expert-Evaluated Outcome of a Randomized Clinical Trial for Macular Telangiectasia Type 2 Treatment
Publication
, Conference
Loo, J; Clemons, TE; Chew, EY; Friedlander, M; Jaffe, GJ; Farsiu, S
Published in: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
July 1, 2019
Duke Scholars
Published In
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
EISSN
1552-5783
ISSN
0146-0404
Publication Date
July 1, 2019
Volume
60
Issue
9
Location
Vancouver, CANADA
Publisher
ASSOC RESEARCH VISION OPHTHALMOLOGY INC
Conference Name
Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
Related Subject Headings
- Ophthalmology & Optometry
- 3212 Ophthalmology and optometry
- 11 Medical and Health Sciences
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Loo, J., Clemons, T. E., Chew, E. Y., Friedlander, M., Jaffe, G. J., & Farsiu, S. (2019). Automatic Deep Learning OCT Analysis Algorithm Reliably Reproduces Expert-Evaluated Outcome of a Randomized Clinical Trial for Macular Telangiectasia Type 2 Treatment. In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (Vol. 60). Vancouver, CANADA: ASSOC RESEARCH VISION OPHTHALMOLOGY INC.
Loo, Jessica, Traci E. Clemons, Emily Y. Chew, Martin Friedlander, Glenn J. Jaffe, and Sina Farsiu. “Automatic Deep Learning OCT Analysis Algorithm Reliably Reproduces Expert-Evaluated Outcome of a Randomized Clinical Trial for Macular Telangiectasia Type 2 Treatment.” In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, Vol. 60. ASSOC RESEARCH VISION OPHTHALMOLOGY INC, 2019.
Loo J, Clemons TE, Chew EY, Friedlander M, Jaffe GJ, Farsiu S. Automatic Deep Learning OCT Analysis Algorithm Reliably Reproduces Expert-Evaluated Outcome of a Randomized Clinical Trial for Macular Telangiectasia Type 2 Treatment. In: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. ASSOC RESEARCH VISION OPHTHALMOLOGY INC; 2019.
Loo, Jessica, et al. “Automatic Deep Learning OCT Analysis Algorithm Reliably Reproduces Expert-Evaluated Outcome of a Randomized Clinical Trial for Macular Telangiectasia Type 2 Treatment.” INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, vol. 60, no. 9, ASSOC RESEARCH VISION OPHTHALMOLOGY INC, 2019.
Loo J, Clemons TE, Chew EY, Friedlander M, Jaffe GJ, Farsiu S. Automatic Deep Learning OCT Analysis Algorithm Reliably Reproduces Expert-Evaluated Outcome of a Randomized Clinical Trial for Macular Telangiectasia Type 2 Treatment. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. ASSOC RESEARCH VISION OPHTHALMOLOGY INC; 2019.
Published In
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
EISSN
1552-5783
ISSN
0146-0404
Publication Date
July 1, 2019
Volume
60
Issue
9
Location
Vancouver, CANADA
Publisher
ASSOC RESEARCH VISION OPHTHALMOLOGY INC
Conference Name
Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
Related Subject Headings
- Ophthalmology & Optometry
- 3212 Ophthalmology and optometry
- 11 Medical and Health Sciences
- 06 Biological Sciences